Close Menu

NEW YORK – Kantaro Biosciences, a joint venture of Mount Sinai Health System and RenalytixAI, announced on Tuesday that it has entered a marketing a distribution agreement with Atrys Health to distribute Kantaro's SARS-CoV-2 antibody tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.